04341nam 2200721 a 450 99620719180331620230725022809.01-283-35238-90-19-161797-09786613352385(CKB)2560000000293599(EBL)3054353(OCoLC)757423602(SSID)ssj0000533983(PQKBManifestationID)11359966(PQKBTitleCode)TC0000533983(PQKBWorkID)10491777(PQKB)11343625(StDuBDS)EDZ0000038593(MiAaPQ)EBC3054353(MiAaPQ)EBC7039037(Au-PeEL)EBL7039037(EXLCZ)99256000000029359920110509d2011 uy 0engur|n|---|||||txtccrAncient slavery and abolition[electronic resource] from Hobbes to Hollywood /edited by Edith Hall, Richard Alston, and Justine McConnellOxford Oxford University Press20111 online resource (528 p.)Classical presencesDescription based upon print version of record.0-19-957467-7 0-19-172872-1 Includes bibliographical references (p. [425]-466) and index.""Cover""; ""Contents""; ""List of Contributors""; ""List of Illustrations""; ""1. Introduction: �AValuable Lesson�""; ""2. The Good Master: Pliny, Hobbes, and the Nature of Freedom""; ""3. Appropriations of Spartan Helotage in British Anti-Slavery Debates of the 1790s""; ""4. The Influence of Classical Ideas on the Anti-Slavery Debate at the Cape of Good Hope, South Africa (1795�1834)""; ""5. A Stronger Muse: Classical Influences on Eighteenth-Century Abolitionist Poetry""; ""6. The Politics of Classicism in the Poetry of Phillis Wheatley""""7. Between Victimhood and Agency: Nydia the Slave in Bulwer�s The Last Days of Pompeii""""8. The Problem with Prometheus: Myth, Abolition, and Radicalism""; ""9. Recollecting Aristotle: Pro-Slavery Thought in Antebellum America and the Argument of Politics Book I""; ""10. The Auctoritas of Antiquity: Debating Slavery through Classical Exempla in the Antebellum USA""; ""11. Yankee She-Men and Octoroon Electra: Basil Lanneau Gildersleeve on Slavery, Race, and Abolition""; ""12. Universal Slave Revolts: C. L. R. James�s Use of Classical Literature in The Black Jacobins""""13. Eumaeus and Eurycleia in the Deep South: Odyssean Slavery in Sommersby""""Postscript: Slavery, Abolition, Modernity, and the Past""; ""Consolidated Bibliography""; ""Index""; ""A""; ""B""; ""C""; ""D""; ""E""; ""F""; ""G""; ""H""; ""I""; ""J""; ""K""; ""L""; ""M""; ""N""; ""O""; ""P""; ""Q""; ""R""; ""S""; ""T""; ""U""; ""V""; ""W""; ""X""; ""Z"""Originating in a conference organised in 2007 by the Centre for the Reception of Greece and Rome at Royal Holloway, University of London, and held at the British Library ... this accessible volume offers a pathbreaking study of the role played by the interpreters of ancient Greek and roman texts in the debates over the abolition of slavery. Focusing on Britain, North America, the Caribbean, and South Africa from the late 17th century, the essays examine the arguments of critics and defenders of slavery and legacy of slavery, in later periods." --Book jacket.Classical presences.SlaveryHistoryCongressesAntislavery movementsHistoryCongressesClassical literatureCongressesAbolitionistsHistoryCongressesSlaveryHistoryAntislavery movementsHistoryClassical literatureAbolitionistsHistory306.362Hall Edith1959-283486Alston Richard1965-309636McConnell Justine1017425University of London.Royal Holloway.Centre for the Reception of Greece and Rome.British Library.MiAaPQMiAaPQMiAaPQBOOK996207191803316Ancient slavery and abolition2386440UNISA04751nam 2200613Ia 450 991077951630332120230721010724.01-60876-726-4(CKB)2550000001041251(EBL)3018284(SSID)ssj0000852872(PQKBManifestationID)12365025(PQKBTitleCode)TC0000852872(PQKBWorkID)10864464(PQKB)11206701(MiAaPQ)EBC3018284(Au-PeEL)EBL3018284(CaPaEBR)ebr10660145(OCoLC)923657824(EXLCZ)99255000000104125120090330d2009 uy 0engur|n|---|||||txtccrMolecular therapy of breast cancer[electronic resource] classicism meets modernity /Marc LacroixNew York Nova Biomedical Booksc20091 online resource (303 p.)Cancer etiology, diagnosis and treatments seriesDescription based upon print version of record.1-60741-593-3 Includes bibliographical references and index.""Molecular Therapy of Breast Cancer: Classicism Meets Modernity""; ""Dedication""; ""Contents ""; ""Preface""; ""Introduction ""; ""References ""; ""Selective Estrogen Receptor Modulators (SERMs) and Down-Regulators (SERDs)""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Selective Estrogen Receptor Modifiers (SERMs) ""; ""Tamoxifen ""; ""Toremifene ""; ""Fulvestrant ""; ""Conclusion ""; ""References ""; ""Aromatase Inhibitors ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Anastrozole ""; ""Letrozole ""; ""Exemestane """"Conclusion """"References ""; ""Agents Inducing Ovarian Suppression ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Goserelin ""; ""Triptorelin""; ""Leuprolide ""; ""Conclusion ""; ""References ""; ""Antimetabolites ""; ""Abstract ""; ""Introduction""; ""Clinical Trials in January 2009 ""; ""Fluorouracil ""; ""Capecitabine ""; ""Gemcitabine ""; ""Pemetrexed ""; ""Methotrexate ""; ""Conclusion ""; ""References""; ""Alkylating Agents ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Cyclophosphamide """"Platinum Compounds (Cisplatin, Carboplatin, Oxaliplatin, Picoplatin) - Generalities """"Cisplatin ""; ""Carboplatin ""; ""Oxaliplatin ""; ""Picoplatin ""; ""Temozolomide ""; ""Thiotepa""; ""Ifosfamide ""; ""Melphalan ""; ""Busulfan ""; ""Conclusion ""; ""References ""; ""Anthracyclines ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Doxorubicin ""; ""Liposomal Doxorubicin ""; ""Epirubicin ""; ""Conclusion ""; ""References""; ""Microtubule-Binding Agents ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Taxanes - Generalities """"Larotaxel """"Docetaxel ""; ""Paclitaxel and Nab-Paclitaxel ""; ""Epothilones - Generalities ""; ""Ixabepilone ""; ""Patupilone ""; ""Sagopilone ""; ""Vinca Alkaloids - Generalities ""; ""Vinorelbine""; ""Vinflunine ""; ""Eribulin ""; ""Conclusion ""; ""References ""; ""Topoisomerase Inhibitors ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Irinotecan ""; ""Etoposide ""; ""Conclusion ""; ""References""; ""HER Family Inhibitors ""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Trastuzumab ""; ""Lapatinib ""; ""Gefitinib """"Erlotinib """"Pertuzumab ""; ""Cetuximab ""; ""Ertumaxomab ""; ""Neratinib ""; ""Trastuzumab-MCC-DM1 ""; ""BIBW 2992 ""; ""ARRY-334543 ""; ""Conclusion ""; ""References ""; ""Angiogenesis Inhibitors ""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Bevacizumab""; ""Sunitinib ""; ""Vandetanib ""; ""Pazopanib ""; ""Ramucirumab ""; ""ABT-869 ""; ""AV-951 ""; ""PTC299""; ""AMG 386 ""; ""Aflibercept ""; ""Conclusion""; ""References ""; ""Insulin-Like Growth Factor-I Receptor (IGF-1R) Inhibitors""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009""""Cixutumumab""Cancer etiology, diagnosis, and treatments.BreastCancerMolecular aspectsAntineoplastic agentsBreastCancerMolecular aspects.Antineoplastic agents.362.196/99449362.196/99449Lacroix Marc1963-1492984MiAaPQMiAaPQMiAaPQBOOK9910779516303321Molecular therapy of breast cancer3846114UNINA